Fusion Pharmaceuticals Inc [FUSN] Revenue clocked in at $2.21 million, up 120.40% YTD: What’s Next?
Fusion Pharmaceuticals Inc [NASDAQ: FUSN] gained 99.06% on the last trading session, reaching $21.18 price per share at the time. The company report on March 19, 2024 at 3:00 AM that Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat